Kas, B., Talbot, H., Ferrara, R., Richard, C., Lamarque, J., Pitre-Champagnat, S., . . . Caramella, C. (2020). Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer. JAMA Oncol.
Citação norma ChicagoKas, Baptiste, et al. "Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer." JAMA Oncol 2020.
Citação norma MLAKas, Baptiste, et al. "Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer." JAMA Oncol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.